D-Index & Metrics Best Publications

Ronald Ghossein

Memorial Sloan Kettering Cancer Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 85 Citations 25,519 249 World Ranking 9610 National Ranking 5081

Overview

What is he best known for?

The fields of study Ronald Ghossein is best known for:

Cancer
Gene
Colorectal cancer

Ronald Ghossein works mostly in the field of Nodule (geology), limiting it down to topics relating to Paleontology and, in certain cases, Context (archaeology), as a part of the same area of interest. Ronald Ghossein combines topics linked to Paleontology with his work on Context (archaeology). The Thyroid cancer portion of his research involves studies in Papillary thyroid cancer and Anaplastic thyroid cancer. Ronald Ghossein performs integrative study on Papillary thyroid cancer and Colorectal cancer. He conducts interdisciplinary study in the fields of Colorectal cancer and Cancer research through his research. Ronald Ghossein incorporates Cancer research and Metastasis in his studies. His Metastasis research is covered under the topics of Primary tumor and Distant metastasis. His Genetics research extends to Anaplastic thyroid cancer, which is thematically connected. In his work, he performs multidisciplinary research in Genetics and Mutation.

His most cited work include:

Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System (717 citations)
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance (266 citations)
Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS) (250 citations)

What are the main themes of his work throughout his whole career to date

In the field of Pathology Ronald Ghossein connects related research areas like Carcinoma, Immunohistochemistry, Lymph node and Salivary gland. Ronald Ghossein is researching Cancer as part of the investigation of Thyroid cancer and Metastasis. His Thyroid investigation overlaps with Thyroid cancer and Thyroidectomy. He undertakes interdisciplinary study in the fields of Internal medicine and Surgery through his research. He undertakes multidisciplinary studies into Surgery and Internal medicine in his work. He combines topics linked to Thyroid with his work on Thyroid carcinoma. He incorporates Oncology and Cancer in his studies. Ronald Ghossein carries out multidisciplinary research, doing studies in Cancer research and Genetics. His multidisciplinary approach integrates Genetics and Cancer research in his work.

Ronald Ghossein most often published in these fields:

Internal medicine (89.06%)
Pathology (75.00%)
Cancer (57.81%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)

1341 Citations

Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)

1275 Citations

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

Yuri E. Nikiforov;Raja R. Seethala;Giovanni Tallini;Zubair W. Baloch.
JAMA Oncology (2016)

1201 Citations

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha.
Journal of Clinical Investigation (2016)

757 Citations

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman.
The New England Journal of Medicine (2013)

734 Citations

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

R. Michael Tuttle;Hernan Tala;Jatin Shah;Rebecca Leboeuf.
Thyroid (2010)

637 Citations

Mutational Profile Of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA and AKT1

Julio C. Ricarte-Filho;Mabel Ryder;Dhananjay A. Chitale;Michael Rivera.
Cancer Research (2009)

591 Citations

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)

562 Citations

Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Jeffrey Liu;Bhuvanesh Singh;Giovanni Tallini;Diane L. Carlson.
Cancer (2006)

527 Citations

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

Michael Rivera;Julio Ricarte-Filho;Jeff Knauf;Ashok Shaha.
Modern Pathology (2010)

418 Citations

If you think any of the details on this page are incorrect, let us know.